Pharma-Bio Financial Statements From 2010 to 2024
| PBSV Stock | USD 0.48 0.02 4.00% |
Check Pharma-Bio Serv financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharma-Bio Serv's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharma-Bio financial statements analysis is a perfect complement when working with Pharma-Bio Serv Valuation or Volatility modules.
Pharma-Bio |
Pharma Bio Serv OTC Stock Return On Equity Analysis
Pharma-Bio Serv's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pharma-Bio Serv Return On Equity | 0.0568 |
Most of Pharma-Bio Serv's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharma Bio Serv is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pharma Bio Serv has a Return On Equity of 0.0568. This is 100.24% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 118.32% lower than that of the firm.
Pharma Bio Serv Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharma-Bio Serv's current stock value. Our valuation model uses many indicators to compare Pharma-Bio Serv value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharma-Bio Serv competition to find correlations between indicators driving Pharma-Bio Serv's intrinsic value. More Info.Pharma Bio Serv is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pharma Bio Serv is roughly 1.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharma-Bio Serv's earnings, one of the primary drivers of an investment's value.About Pharma-Bio Serv Financial Statements
Pharma-Bio Serv investors use historical fundamental indicators, such as Pharma-Bio Serv's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pharma-Bio Serv. Please read more on our technical analysis and fundamental analysis pages.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.